partial response


Also found in: Dictionary, Thesaurus, Financial, Acronyms, Encyclopedia.

partial response

Abbreviation: PR
In cancer care, a reduction in the size of readily identifiable tumors by 50% or more.
See also: response
References in periodicals archive ?
Among the partial response patients, one patient within 3 months and 4 within six months developed cholangitis.
* Of 11 patients with measurable disease, one patient treated with a 264mg/m2 dose, achieved a durable partial response, including a PSA decline of more than 50 percent .
Of 102 patients with both fibromyalgia and vestibulitis, only 36% had a complete response of their vestibulitis and 55% had a partial response.
A partial response was defined as a contact with the lever that did not result in a complete leverpress.
In partial response to your request, please find the enclosed documents of the Civil Rights Division dated January, 1961, through December, 1963 of Reel Six (6).
Both studies showed disease control with patients exhibiting partial response and stable disease, White tells investors in a research note.
The overall response rate was 32% (19/59), with 29% (17/59) achieving a partial response and two patients achieving a very good partial response.
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) announced that the US Food and Drug Administration (FDA) has approved Lynparza for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy, as detected by an FDA-approved companion diagnostic test.
AstraZeneca Plc (LSE:AZN), a global, science-led biopharmaceutical company and global pharmaceutical company Merck & Co Inc (NYSE:MRK) (known as MSD outside the US and Canada) announced on Monday detailed results from the phase III SOLO-1 trial testing Lynparza (olaparib) tablets as a maintenance treatment for patients with newly-diagnosed, advanced BRCA-mutated (BRCAm) ovarian cancer, who were in complete or partial response following first-line standard platinum-based chemotherapy.
Stringent complete response (sCR) was reported in 2.8% of patients, very good partial response (VGPR) was reported in' 9.4% of patients, and partial response (PR) was reported in 17% of patients.
Patients were evaluated after 1st week, 2nd week, 4th week and 6th week by same dermatologist and response of treatment was recorded in the form of No response (NR), Partial response (PR) and complete response (CR).

Full browser ?